Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07255937

PMCF Study of Debridement Pad

Led by Advanced Medical Solutions Ltd. · Updated on 2025-12-01

184

Participants Needed

1

Research Sites

33 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The design of the study is a clinical trial of Debridement Pad in subjects with superficial, chronic and acute wounds consisting of Diabetic ulcers, Arterial and Venous Leg ulcers, Pressure ulcers, Postoperative wounds healing by secondary intention, traumatic or surgical wounds and burns and scalds. The performance data from this study will support clinically meaningful rates of successful improvement in wound bed condition immediately after treatment.

CONDITIONS

Official Title

PMCF Study of Debridement Pad

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Males or females aged 18 years or above
  • Patients who can understand and provide informed consent
  • Have one or more of the following wounds: diabetic ulcers, arterial and venous leg ulcers, pressure ulcers, postoperative wounds healing by secondary intention, traumatic or surgical wounds, burns and scalds
  • Wounds requiring debridement due to slough debris, fibrous tissue, hyperkeratotic debris, or dried exudate on peri-wound skin
  • Wounds with both serous crusts and healthy tissue
  • At least 30% of the wound covered by debris, necrosis, or slough
  • Wound size greater than 4 cm2
Not Eligible

You will not qualify if you...

  • Known non-compliance with medical treatment
  • Known sensitivity to device components such as polyester
  • Significant or unstable medical or psychiatric condition affecting study participation
  • Currently enrolled in another clinical study or completed one less than 30 days before enrollment
  • Symptoms or signs of systemic or spreading wound infection, including erythema and fever
  • Severe pain rated 7 or higher on a 0-10 scale or hyperaesthesia in the wound area
  • Investigator judgment of unsuitability for study inclusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Clínica Cres

Madrid, Spain

Actively Recruiting

Loading map...

Research Team

C

Charlotte E Moss, PhD

CONTACT

R

Rebecca Forder, BA (Hons)

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here